Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 501–600 of 935
CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists
Markossian, S., & Flamant, F. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0305 · Cited by 13
Borowicz, P., Chan, H., Medina, D., Gumpelmair, S., Kjelstrup, H., & Spurkland, A. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12862 · Cited by 12
Knockdown of Human AMPK Using the CRISPR/Cas9 Genome-Editing System
Grenier, A., Sujobert, P., Olivier, S., Guermouche, H., Mondésir, J., Kosmider, O., Viollet, B., & Tamburini, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7598-3_11 · Cited by 11
“Alternatively, DSB may be repaired by homologous recombination (HR), which may be exploited for targeted mutagenesis of endogenous genes when using a mutated recombination template [4].”
BackgroundMiyamoto, T., Akutsu, S. N., Tauchi, H., Kudo, Y., Tashiro, S., Yamamoto, T., & Matsuura, S. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry007 · Cited by 11
“THE EEN-MEDIATED SINGLE-BASE-PAIR EDITING TECHNIQUE MIGHT ENABLE DIRECT EVALUATION OF SINGLE-NUCLEOTIDE VARIATION (SNV) UNDERLYING CELLULAR RADIOSENSITIVITY To confirm whether SNVs in the DNA repair genes related to various cancer risks influence the cellular radiosensitivity directly, cointroduction of EENs and 100–2…”
BackgroundEfficient visual screening of CRISPR/Cas9 genome editing in the nematode Pristionchus pacificus
Hiraga, H., Ishita, Y., Chihara, T., & Okumura, M. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12761 · Cited by 11
“For precise genome editing by HDR, add 1 µl of the repair template (ssODN, 10 µM).”
BackgroundInfluentialPolikarpova, A. V., Egorova, T. V., Lunev, E. A., Tsitrina, A. A., Vassilieva, S. G., Savchenko, I. M., Silaeva, Y. Y., Deykin, A. V., & Bardina, M. V. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1034720 · Cited by 11
“The intronic mutation C>A incorporated more frequently in agreement with short (<5 nt) cut-to-mutation distance as compared to G>A substitution located 20 nucleotides from the CRISPR/Cas9 cleavage site (Paquet et al., 2016).”
BackgroundSchistosome Transgenesis: The Long Road to Success
Kalinna, B. H., Ross, A. G., & Walduck, A. K. (2024) · Biology · doi:10.3390/biology13010048 · Cited by 10
Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders
Bhushan, B., Singh, K., Kumar, S., & Bhardwaj, A. (2024) · Current Gene Therapy · doi:10.2174/0115665232292246240426125504 · Cited by 11
Choi, I. Y., Ling, J. P., Zhang, J., Helmenstine, E., Walter, W., Tsakiroglou, P., Bergman, R. E., Philippe, C., Manley, J. L., Rouault‐Pierre, K., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011260 · Cited by 12
Applications and Prospects of CRISPR/Cas9 Technology in the Breeding of Major Tropical Crops
Zhou, L., Zeng, X., Yang, Y., Li, R., & Zhao, Z. (2024) · Plants · doi:10.3390/plants13233388 · Cited by 14
“…repaired through the error-prone non-homologous Then, double-stranded breaks are mainly repaired through the error-prone non-homologous end-joining (NHEJ) pathway or the error-free homology-directed repair (HDR) [27]. end-joining (NHEJ) pathway or the error-free homology-directed repair (HDR) [27].”
Tei, C., Hata, S., Mabuchi, A., Okuda, S., Ito, K. K., Genova, M., Fukuyama, M., Yamamoto, S., Chinen, T., Toyoda, A., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08187-5 · Cited by 18
Edmondson, C., Zhou, Q., & Liu, X. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00707-5 · Cited by 9
“Although this method failed to produce homozygous mutants in a single round (RNP 1), the presence of the silent mutation enabled us to continue to generate homozygous mutants from the heterozygous mutation cell line [22].”
MethodAkhtar, B. M., Bhatia, P., Acharya, S., Sharma, S., Sharma, Y., Devi, A. B. N. S., Ganapathy, K., Vasudevan, A., & Raghu, P. (2022) · Biology Open · doi:10.1242/bio.059066 · Cited by 12
“Since the whole genome sequence of each line has been determined, it is also possible to experimentally test the importance of specific variants in the patient genome by CRISPR/Cas9 genome editing of specific variants (Paquet et al., 2016) followed by phenotypic analysis.”
BackgroundBuilding in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
Pinals, R. L., & Tsai, L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201542 · Cited by 10
“More recently, the CRISPR/Cas9 gene-editing system (among others) has been employed, allowing introduction ofmutations into healthy hiPSCs or, conversely, correction of mutations (Ran et al, 2013; Doudna & Charpentier, 2014; Paquet et al, 2016).”
BackgroundSala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 13
Young, J. E., & Goldstein, L. S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_6 · Cited by 10
Goolab, S., & Scholefield, J. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1464531 · Cited by 10
Prime editing: A gene precision editing tool from inception to present
Liu, Z., Guo, D., Wang, D., Zhou, J., Chen, Q., & Lai, J. (2024) · The FASEB Journal · doi:10.1096/fj.202401692r · Cited by 13
Powerful tools for genetic modification: Advances in gene editing
Roesch, E. A., & Drumm, M. L. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23791 · Cited by 12
Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation
Vesikansa, A. (2018) · Journal of Central Nervous System Disease · doi:10.1177/1179573518787469 · Cited by 10
Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling
Jo, N., Sogabe, Y., Yamada, Y., Ukai, T., Kagawa, H., Mitsunaga, K., Woltjen, K., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13924 · Cited by 10
Functional characterization of two enhancers located downstream FOXP2
Torres-Ruiz, R., Benítez‐Burraco, A., Martínez-Lage, M., Rodríguez, S., & García-Bellido, P. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0810-2 · Cited by 11
CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals
Karapurkar, J. K., Antao, A. M., Kim, K.-S., & Ramakrishna, S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.018 · Cited by 14
Expanding the range of CRISPR/Cas9-directed genome editing in soybean
He, R., Zhang, P., Yan, Y., Chen, Y., Jiang, L., Zhu, Y., & Wang, D. (2021) · aBIOTECH · doi:10.1007/s42994-021-00051-4 · Cited by 11
Highly Efficient CRISPR/Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells
Maguire, J. A., Gadue, P. J., & French, D. L. (2022) · Current Protocols · doi:10.1002/cpz1.590 · Cited by 11
“590 © 2022 Wiley Periodicals LLC. Maguire et al. 1 of 15 mono-allelic sequence modifications, without the introduction of nonspecific indels (Paquet et al., 2016; Richardson, Ray, DeWitt, Curie, & Corn, 2016).”
BackgroundAoshima, T., Kobayashi, Y., Takagi, H., Iijima, K., Sato, M., & Takabayashi, S. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00723-5 · Cited by 10
“that the enhanced efficiency resulted from overlapping gRNAs inducing shorter NHEJ-mediated sequence deletions close to the intended mutation site, which potentially favored HDR [36].”
BackgroundTrambauer, J., Sarmiento, R. M. R., Garringer, H. J., Salbaum, K. A., Pedro, L. D., Crusius, D., Vidal, R., Ghetti, B. F., Paquet, D., Baumann, K., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01680-3 · Cited by 9
“Groups with less than two data points were excluded from the analysis L166P mutation was edited into the parental iPSCs using CRISPR/Cas9 [40, 61] to obtain heterozygous WT/L166P as well as homozygous L166P/L166P cells (Fig.”
Self-citationAge-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Establishment of MDR1-knockout human induced pluripotent stem cell line
Negoro, R., Kawai, K., Ichikawa, M., Deguchi, S., Takayama, K., & Mizuguchi, H. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.01.009 · Cited by 9
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 10
Discovery in CRISPR-Cas9 system.
Pan, S., & Zhang, H. (2021) · PubMed Central · doi:10.11817/j.issn.1672-7347.2021.210169 · Cited by 9
Савченко, Е. С., Сергеевна, О. Н., & Karkischenko, N. N. (2022) · Journal Biomed · doi:10.33647/2074-5982-18-4-10-23 · Cited by 9
Improved selection of zebrafish CRISPR editing by early next-generation sequencing based genotyping
Sieliwończyk, E., Vandendriessche, B., Claes, C., Mayeur, E., Alaerts, M., Holmgren, P., Cremers, T. C., Snyders, D. J., Loeys, B., & Schepers, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-27503-9 · Cited by 9
Matsushita, N., Kato, S., Nishizawa, K., Sugawara, M., Takeuchi, K., Miyasaka, Y., Mashimo, T., & Kobayashi, K. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100393 · Cited by 10
“Although homologous recombination is generally considered to require long homologous sequences,(32,33) recent studies of gene editing with a single-strand template suggest that recombination is also mediated via the homology of relatively shorter sequences.(34,35) In addition, short homologous sequences of 5–25 bp are…”
BackgroundMechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing
Kulishova, L. M., Vokhtantsev, I. P., Kim, D. V., & Zharkov, D. O. (2023) · Molecular Biology · doi:10.1134/s0026893323020139 · Cited by 11
“The approach increased the precision of editing the APP and PSEN1 loci in pluripotent stem cells and the HEK293 cell line by a factor of 2–10 [121, 122].”
Li, X., Ren, C., Huang, A., Zhao, Y., Wang, L., Shen, H., Gao, C., Chen, B., Zhu, T., Xiong, J., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.04.015 · Cited by 10
PINE-TREE enables highly efficient genetic modification of human cell lines.
Frisch, C., Kostes, W. W., Galyon, B., Whitman, B., Tekel, S. J., Standage-Beier, K., Srinivasan, G., Wang, X., & Brafman, D. A. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2023.07.007 · Cited by 9
The Necessity of Diploid Genome Sequencing to Unravel the Genetic Component of Complex Phenotypes
Alemán, F. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00148 · Cited by 9
“Allele-specific diseases can be precisely targeted, without affecting the healthy allele (Paquet et al., 2016), and diploid genomes may enable the discovery of allele-specific protective genetic variants, which could be targeted with CRISPR to improve health.”
BackgroundDeveloping precision medicine using scarless genome editing of human pluripotent stem cells
Steyer, B., Cory, E., & Saha, K. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.02.001 · Cited by 14
“One solution, presented by Paquet and colleagues [54], involves a two-step process where both the intended mutation and a blocking mutation are made with the first ssODN repair.”
BackgroundMasroori, N., Cherry, P., Mérindol, N., Li, J., Dufour, C., Poulain, L., Plourde, M. B., & Berthoux, L. (2017) · mSphere · doi:10.1128/mspheredirect.00233-17 · Cited by 12
“Even if not all alleles of a 183 given gene are successfully modified by knock-in, recent reports indicate that the remaining ones 184 are usually knocked out through NHEJ-dependent mechanisms (41).”
BackgroundGenerating Mutant Renal Cell Lines Using CRISPR Technologies
Perretta‐Tejedor, N., Freke, G., Seda, M., Long, D. A., & Jenkins, D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9841-8_20 · Cited by 9
Mehrjardi, N. Z., Molčányi, M., Hatay, F. F., Timmer, M., Shahbazi, E., Ackermann, J. P., Herms, S., Heilmann‐Heimbach, S., Wunderlich, T. F., Prochnow, N., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12892 · Cited by 9
Medley, J. C., Hebbar, S., Sydzyik, J. T., & Zinovyeva, A. (2021) · Genetics · doi:10.1093/genetics/iyab199 · Cited by 11
“Donor repair templates can be exogenously provided as single-stranded oligodeoxynucleotides (ssODN) or double-stranded DNA (dsDNA) molecules for the purpose of genome editing (Cong et al. 2013; Zhao et al. 2014; Paquet et al. 2016; Yoshimi et al. 2016; Gallagher et al. 2020).”
A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system
Li, X., Sun, B., Qian, H., Ma, J., Paolino, M., & Zhang, Z. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100196 · Cited by 9
“Its efficiency further de‐ creases as the distance between the target site and intro‐ duced mutation increases (Paquet et al., 2016).”
BackgroundMethodInfluentialCRISPR/Cas9-mediated generation of a Plac8 knockout mouse model
Lee, H., Kim, J.-I., Park, J., Roh, J.-I., Lee, J., Kang, B., & Lee, H. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.279 · Cited by 9
“Compared with conventional gene targeting strategies in ES cells, methods using CRISPR/Cas systems enable the manipulation of genes at the single nucleotide level and show increased efficiency for establishing animal models, mimicking human disease phenotypes, in a short period of time [29].”
MethodBosch, J. A., Knight, S. M., Kanca, O., Zirin, J. D., Yang‐Zhou, D., Hu, Y., Rodiger, J., Amador, G. O., Bellen, H. J., Perrimon, N., et al. (2019) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.112 · Cited by 9
“For the standard and ssDNA Drop-In methods, the sgRNA binding site should be close to the homology arms (Paquet et al., 2016).”
MethodPrecision genome-editing with CRISPR/Cas9 in human induced pluripotent stem cellsPreprint
Budde, J., Martinez, R. J., Hsu, S., Wen, N., Chen, J., Coppola, G., Goate, A., Cruchaga, C., & Karch, C. M. M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/187377 · Cited by 10
“Previous studies have demonstrated that introduction of synonymous changes into a donor oligodeoxynucleotide may increase the recovery of clones with desired modifications while reducing NHEJ events at the target site (8,10).”
BackgroundMethodChandrashekar, H., Simándi, Z., Choi, H., Ryu, H.-S., Waldman, A. J., Nikish, A., Muppidi, S. S., Gong, W., Paquet, D., & Phillips‐Cremins, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582395 · Cited by 13
“Thus, we verify previous reports 36, 37 that iPSC-neurons with homozygous FAD mutations in monolayer culture represent a robust model of an early stage of AD onset marked by increase in Aβ monomeric species but prior to Aβ oligomerization, extracellular accumulation of Aβ, or pathological tau…”
InfluentialSelf-citationGenome-wide CRISPR off-target DNA break detection by the BLISS method
Ballarino, R., Bouwman, B. A. M., & Crosetto, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_15 · Cited by 8
Gene Editing for Enhanced Swine Production: Current Advances and Prospects
Ju, W. S., Kim, S., Lee, J.-Y., Lee, H., No, J.-G., Lee, S., & Oh, K. B. (2025) · Animals · doi:10.3390/ani15030422 · Cited by 15
“Alternatively, when donor templates or oligonucleotides are available, the HDR pathway can be employed to introduce precise modifications from the donor template at the nucleotide level [75–77].”
Labra, S. R., Compher, J., Prabhavalkar, A., Almaraz, M., Kwong, C. C., Baal, C., Talantova, M. V., Dolatabadi, N., Piña‐Sanz, J., Wang, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202514783 · Cited by 13
“We used the previously established and characterized [ 35, 55 ] isogenic heterozygous PSEN1 M146V /WT and APP Swe /WT mutant hiPSCs, along with their WT 7889SA parental (WT/WT) line (termed isogenic set 1), obtained from the laboratory of Marc Tessier-Lavigne (for mutant lines) and the New York…”
Precision genome editing with DNA base editors
Mawson, S. J., Dunne-Dombrink, K., Pollak, B. R., & Komor, A. C. (2026) · Nature Reviews Methods Primers · doi:10.1038/s43586-026-00478-3 · Cited by 9
Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
Huang, K., Tian, J., Zhao, W., Zhang, S., Xiang, L., Yang, M., Ls, L., Huang, Y., Zhang, N., Sun, L., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70115 · Cited by 9
Billaud, A., Chevalier, L.-M., Augereau, P., Frenel, J., Passot, C., Campone, M., & Morel, A. (2021) · Genome Medicine · doi:10.1186/s13073-021-00976-x · Cited by 9
“The PAM sequence had to be adjacent to the variant to facilitate the editing of KO LIG4 HAP1 cells [30].”
BackgroundMethodInfluentialChong, C., Tan, Y., Tong, J., Ke, M., Zhang, K., Yan, L., Cen, X., Lu, J., Chen, G., Su, H., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00874-8 · Cited by 11
“This suggests that the double selection system of CRISPR/Cas9/ piggyBac is an effective approach to introduce heterozygous and homozygous mutations in human iPSCs.”
BackgroundInfluentialAdji, A. S., Widjaja, J. S., Wardani, V. A. K., Muhammad, A. H., Handajani, F., Putra, H. B. P., & Rahman, F. S. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9053 · Cited by 9
“PSEN1M1 Disease models generated by CRISPR [67] APPS Disease models generated by CRISPR [67] APP Attenuation of b-cleavage and Ab production [68] PSEN2 Normalization of enhanced levels of Ab42/40 through CRISPR/Cas to correct the mutation in PSEN2N141I [69]”
MethodGABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model
Chen, C., Tang, X., Lan, Z., Wan, C., Su, H., Li, W., Li, Y., Zhou, X. W., Gao, H., Feng, X., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.05.003 · Cited by 9
CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures
Fan, M., Bao, Y., Berkhout, B., & Herrera-Carrillo, E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115046 · Cited by 8
Hammad, R., Alzubi, J., Rhiel, M., Chmielewski, K. O., Mosti, L., Rositzka, J., Heugel, M., Lawrenz, J., Pennucci, V., Gläser, B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020985 · Cited by 10
“While NHEJ-based gene disruption approaches in pluripotent cells have been successful [9,10], HDR frequencies in iPSCs tended to be low when plasmid-based HDR templates were used [11,12].”
BackgroundPrecision epitope editing: A path to advanced immunotherapies
Ji, R.-J., Wang, M.-Y., & Zhang, Y. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100226 · Cited by 8
CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines
Sanjurjo-Soriano, C., Erkilic, N., Mamaeva, D. V., & Kalatzis, V. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_362 · Cited by 9
Gong, L., Liu, X., Wu, J., & He, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01292-x · Cited by 11
“For example, human-induced pluripotent stem cells (hiPSC) carrying dominant mutations in amyloid precursor protein (APP) and presenilin 1 (PSEN) were generated to study early-onset AD [14].”
BackgroundGong, K. Q., Xie, T., Yang, Y., Luo, Y., Deng, Y., Chen, K., Tan, Z., Guo, H., & Xie, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763851 · Cited by 8
“The latest gene-editing technology, CRISPR/Cas9, has been widely used in studies of various gene knockout biological models such as mice, zebrafish, and chicken (37).”
BackgroundDevelopment and Optimization of CRISPR Prime Editing System in Photoautotrophic Cells
Jiang, Z., Abdullah, A., Zhang, S., Jiang, Y., Liu, R., & Xiao, Y. (2022) · Molecules · doi:10.3390/molecules27061758 · Cited by 9
“This was followed by the introduction of a donor template, along with a reliance on cell repair machinery, either homologues repair (HR) or non-homologues end-joining (NHEJ), for insertion or deletion of the sequence [2].”
MethodXie, L., Hu, Y. F., Li, L., Jiang, L., Jiao, Y., Wang, Y., Zhou, L., Tao, R. X., Qu, J., Chen, Q., et al. (2022) · FEBS Journal · doi:10.1111/febs.16457 · Cited by 9
A kaleidoscopic view of extracellular vesicles in lysosomal storage disorders
Hegeman, C. V., de Jong, O. G., & Lorenowicz, M. J. (2022) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2022.41 · Cited by 9
Expanding the RNA-Guided Endonuclease Toolkit for Mouse Genome Editing
Robertson, L. J., Pederick, D. T., Piltz, S., White, M. A., Guil, A. F. N., Ahladas, M., Adikusuma, F., & Thomas, P. Q. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0050 · Cited by 10
Jarazo, J., Qing, X., & Schwamborn, J. C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00190 · Cited by 8
“Due to the high number of clones that needed to be screened to obtain a positive one (Paquet et al., 2016), alternatives techniques were needed by the research community.”
MethodZhao, Z., Gong, C., Gao, Y., Liu, X., Wu, S., Zhao, H., Wang, X., Liu, H., Chen, X., Liu, J., et al. (2020) · International Journal of Hypertension · doi:10.1155/2020/9185697 · Cited by 10
“In addition, emerging technologies have been developed to repair DNA by editing the wrong bases [26, 27].”
BackgroundRole of RS-1 derivatives in homology-directed repair at the human genome ATG5 locus
Jeon, I.-S., Shin, J., Kim, S. R., Park, K. S., Yoo, H. J., Lee, K. Y., Lee, H., & Choi, J.-K. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01226-1 · Cited by 8
Rapid repair of human disease-specific single-nucleotide variants by One-SHOT genome editing
Yokouchi, Y., Suzuki, S., Ohtsuki, N., Yamamoto, K., Noguchi, S., Soejima, Y., Goto, M., Ishioka, K., Nakamura, I., Suzuki, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70401-7 · Cited by 10
Brandão, K. O., Grandela, C., Yiangou, L., Mummery, C. L., & Davis, R. P. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_368 · Cited by 12
A stress-free strategy to correct point mutations in patient iPS cells
Cai, J., Kropf, E., Hou, Y., & Iacovitti, L. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102332 · Cited by 9
Boddu, P. C., Gupta, A. K., Kim, J.-S., Neugebauer, K. M., Waldman, T. A., & Pillai, M. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02690-1 · Cited by 8
Therapeutic perspectives for structural and functional abnormalities of cilia
Kim, Y. J., & Kim, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03158-6 · Cited by 13
Paix, A., Rasoloson, D., Folkmann, A. W., & Seydoux, G. (2019) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.102 · Cited by 13
“We recommend a crRNA with 50% GC content and a 3′ G in the spacer sequence that will cleave within a 10-bp window of the desired fluorescent reporter insertion site (Doench et al., 2014; Gagnon et al., 2014; Paix, Folkmann, Goldman, et al., 2017; Paquet et al., 2016).”
BackgroundMethodYang, T., Xu, Y. R., Jin, S., Ramalingam, N., Bellier, J., Lish, A. M., Ostaszewski, B. L., Young‐Pearse, T. L., Liu, L., Yang, H., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01802-x · Cited by 7
“We used the new plate-based oAb assay to quantify the conditioned media (CM) from human induced pluripotent stem cells (iPSCs, DIV 21) harboring certain familial Alzheimer’s Disease (FAD) [26] mutations known to shift Aβ production.”
Torriano, S., Baulier, E., Diaz, A. G., Corneo, B., & Farber, D. B. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0110 · Cited by 9
Umbach, A., Maule, G., Kheir, E., Cutarelli, A., Foglia, M., Guarrera, L., Fava, L. L., Conti, L., Garattini, E., Terao, M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03135-0 · Cited by 7
“As donor we used a single strand oligonucleotide (ssODN-CdLS) carrying the correct NIPBL sequence and two additional silent mutations located in the seed region of the complementary sgRNA to prevent recutting after correction[44] (Fig, 1A and Additional file 2: Table S1).”
MethodRAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
Wong, S. Y., Tan, Y. X., Loh, A., Tan, K. Y., Lee, H., Aziz, Z., Nelson, S. F., Özkan, E., Kayserili, H., Escande‐Beillard, N., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217078 · Cited by 7
“(Paquet et al, 2016) For HDR, a single-stranded oligodeoxynucleotide (ssODN) with 40 bp homology arms flanking the desired c.1628C>T (p.T543M) and c.1632G>C (PAM disruption, synonymous) mutations was designed.”
BackgroundApplication of CRISPR-Cas9 Technology in Fish
Aich, N., Parhi, J., Mandal, S. C., & Sahoo, L. (2023) · Springer eBooks · doi:10.1007/978-981-99-2981-8_2 · Cited by 10
In vitro human cell culture models in a bench‐to‐bedside approach to epilepsy
Danačíková, Š., Straka, B., Daněk, J., Kořínek, V., & Otáhal, J. (2024) · Epilepsia Open · doi:10.1002/epi4.12941 · Cited by 8
Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance
Wang, W., Liang, Z., Ma, P., Zhao, Q., Dai, M., Zhu, J., Xu, H., Xu, H., Chang, Q., & Zhen, Y. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00627 · Cited by 7
A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis
Uyar, O., Plante, P.-L., Piret, J., Venable, M.-C., Carbonneau, J., Corbeil, J., & Boivin, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-98047-z · Cited by 8
The use of base editing technology to characterize single nucleotide variants
McDaniel, S., Komor, A. C., & Goren, A. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.031 · Cited by 10
“An additional challenge with knock-in experiments is that the HDR efficiency drops precipitously as the distance between the DSB and the intended edit site increases [71].”
BackgroundGe, N., Liu, M., Li, R., Allen, N. M., Galvin, J., Shen, S., O’Brien, T., & Prendiville, T. W. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10602-5 · Cited by 7
Yang, M. G., & West, A. E. (2016) · PubMed Central · Cited by 7
Lin, G., Zhang, K., Peng, R., Han, Y., Xie, J., & Li, J. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.02.002 · Cited by 9
Generating Neural Stem Cells from iPSCs with Dopaminergic Neurons Reporter Gene
Hong, H., & Daadi, M. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9007-8_9 · Cited by 7
Trionfini, P., Ciampi, O., Todeschini, M., Ascanelli, C., Longaretti, L., Perico, L., Remuzzi, G., Benigni, A., & Tomasoni, S. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0048 · Cited by 7
Watanabe, K., Nakamura, T., Onodera, S., Saito, A., Shibahara, T., & Azuma, T. (2020) · Tumor Biology · doi:10.1177/1010428320962588 · Cited by 7
Li, J., Zhou, Z., Sun, H., Ouyang, W., Dong, G., Liu, T., Ge, L., Zhang, X., Liu, C., & Gu, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.577053 · Cited by 7
“To generate the HBB −28(A>G) mutation, sgRNA mediating DNA cleavage 3 bp aside from the −28 mutation site and assODNs with 36 bp on the PAM-distal side and 91 bp on the PAM-proximal side of the cutting site were used (Figure 1B).”
MethodInfluentialModeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements
Braverman-Gross, C., & Benvenisty, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622940 · Cited by 8
Baik, R., Wyman, S. K., Kabir, S., & Corn, J. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247858 · Cited by 8
“Because increasing distances between Cas9 cut site and donor-encoded mutations can reduce HDR efficiency, we chose to further pursue sgRNA-4 and sgRNA-6 due to their close proximity to the desired edit site [33, 34].”
BackgroundGenome editing technologies and their potential to treat neurologic disease
Madigan, N. N., Staff, N. P., Windebank, A. J., & Benarroch, E. E. (2017) · Neurology · doi:10.1212/wnl.0000000000004558 · Cited by 7
“Further challenges entail how to control whether an integration event will occur in one or both chromosomal alleles.(31) CRISPR–Cas9 ex vivo gene-edited cell therapies are actively being used in hematology and oncology human clinical trials, and are paving the way forward for neuro-oncology applications, where the pri…”
BackgroundA CRISPR/Cas9 method to generate heterozygous alleles in Saccharomyces cerevisiae
EauClaire, S. F., & Webb, C. J. (2019) · Yeast · doi:10.1002/yea.3432 · Cited by 8
“These methods should be applicable to other diploid organisms: a method similar to the PAM site blocking technique was published for human cells (Paquet et al., 2016).”
MethodRapid Evaluation of CRISPR Guides and Donors for Engineering Mice
McBeath, E., Parker‐Thornburg, J., Fujii, Y., Aryal, N. K., Smith, C. N., Hofmann, M.-C. C., Abe, J., & Fujiwara, K. (2020) · Genes · doi:10.3390/genes11060628 · Cited by 7
“Given the relatively high cutting rate using these guides, this implies that the silent mutation in the PAM or guide RNA seed region sequence was effective in preventing additional editing of genomic DNA that had incorporated the silent mutation [9].”
BackgroundInfluentialCRISPR Technology: Transforming the Future of Medicine and Diagnostics
Iyer, K. A., Tenchov, R., Diaz, L. M. L., Jain, P., Thite, T., Deng, Y., & Zhou, Q. A. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00480 · Cited by 13
Dannert, A., Schulz, N., Klimmt, J., Knez, L., Groschup, B., Gonçalves, C. C., Carraro, C., Schifferer, M., Brendel, M., & Paquet, D. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adu9845 · Cited by 8
Self-citationZhu, H., Wang, L., Wang, Y., Jiang, X., Qin, Q., Song, M., & Huang, Q. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05263-7 · Cited by 8
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.